Value proposition

Targeted treatment of serious infections

mycoBiologics is a University of Aberdeen biotech spinout company which is dedicated to developing new antibody therapies to improve the survival of patients suffering from life-threatening, drug-resistant infections.

Antibody therapy, Anti-infectives, Antifungal, Antibacterial, and Drug discovery